A61P 33 - Antiparasitic agents

Patents for A61P 33 - Antiparasitic agents (21,787)
11/2002
11/21/2002	US20020173049 Controlling protein levels in eucaryotic organisms
11/21/2002	US20020172692 Vaccine composition against malaria
11/21/2002	CA2447576A1 Use of hmg fragment as anti-inflammatory agents
11/21/2002	CA2447395A1 Targeted delivery of drugs for the treatment of parasitic infections
11/21/2002	CA2447184A1 5-cyano-1h-indole derivatives as antagonists of the interleukine-8 receptors
11/21/2002	CA2447116A1 Methods for treating liver disease and liver damage with growth hormone and foxm1b
11/21/2002	CA2447084A1 Benzamidoacetonitriles and their use as antiparasitics
11/21/2002	CA2446589A1 Methods for treating cancer
11/21/2002	CA2445366A1 Molecules for disease detection and treatment
11/20/2002	EP1257585A2 Antibodies that bind human interleukin-18 and methods of making and using
11/20/2002	EP1257578A2 Transporters and ion channels
11/20/2002	EP1257538A2 9-alkylamino-1-nitroacridine derivatives
11/20/2002	EP1257304A1 Foam-forming wound dressing
11/20/2002	EP1257281A1 Nucleoside analogs with carboxamidine modified monocyclic base
11/20/2002	EP1257265A2 Use of 2-phenylene diamine derivatives for the treatment of infections
11/20/2002	EP0917465B1 Antimalarial and anti-babesiosis agents and pharmaceutical compositions containing the same agents
11/20/2002	CN1380884A Novel recombinant antibodies, amino acid sequences of CDR thereof and genes encoding the same
11/19/2002	US6482830 Compositions and formulations of 9-nitrocamptothecin polymorphs and methods of use therefor
11/19/2002	US6482822 N-(iminomethyl)amines derivatives, their preparation, their use as medicines and compositions containing them
11/19/2002	US6482801 Therapy for bacterial or protozoa infections
11/19/2002	US6482618 Self-enhancing, pharmacologically controllable expression systems
11/19/2002	US6482425 Parasiticidal combination
11/14/2002	WO2002090530A2 Kinases and phosphatases
11/14/2002	WO2002089763A1 Pulse-release bolus
11/14/2002	WO2002064616A3 Agonists and antagonists of sphingosine-1-phosphate receptors
11/14/2002	WO2002051233A3 Universal antimicrobial treatment
11/14/2002	WO2002038534A3 Substituted alkyldiamines as inhibitors of plasmepsin or related proteases
11/14/2002	US20020169305 Nucleotide sequences coding polypeptide for use in the treatment and prevention of malaria
11/14/2002	US20020169140 Minimising dosage required of chemotherapeutic agents for their use in antiviral, antibacterial, antiparasitic and anticancer chemotherapy; for treating neoplasms and tumours, viral, bacterial, or parasite infections
11/14/2002	DE10122523A1 New 1,3-dihydroxybenzo-fused decalactone compounds, are cellular kinase inhibitors and hormone receptor inhibitors, useful as e.g. antitumor, anti-infective, antifungal and antiprotozoal drugs
11/14/2002	CA2435142A1 Kinases and phosphatases
11/13/2002	EP1256354A1 Methods for treating cancer
11/13/2002	EP1255762A1 Phosphororganic compounds and the use thereof
11/13/2002	EP1255756A1 Saccharin derivatives as orally active elastase inhibitors
11/13/2002	EP1255724A1 Substituted norbornylamino derivatives, method for the production thereof, use thereof as a medicament or a diagnostic reagent and medicaments containing said compounds
11/13/2002	EP1001962B1 Production of avermectin compounds
11/13/2002	EP0912167B1 Granulates of hexahydropyrazine derivatives which can be administered orally
11/13/2002	CN1379772A Substituted indoles for modulating NFKB activity
11/13/2002	CN1379756A Substituted nor bornylamino derivatives, method for production thereof, use thereof as medicament or diagnostic reagent medicaments containing said compounds
11/13/2002	CN1379047A Match of organic medicine and beta-cyclodextrin derivative and its preparing process
11/13/2002	CN1378789A Application of medical feed for systematic treating fish disease
11/12/2002	US6479660 Process for the preparation of anti-malarial drugs
11/12/2002	US6479544 Therapeutic combinations of fatty acids
11/12/2002	US6479472 Methods of using therapeutic phospholipid derivatives
11/12/2002	CA2049668C Bioerodible implants
11/07/2002	WO2002088316A2 G-protein coupled receptors
11/07/2002	WO2002088107A1 Nitrogenous fused-ring compound having pyrazolyl group as substituent and medicinal composition thereof
11/07/2002	WO2002088106A2 Cysteine protease inhibitors
11/07/2002	WO2002087586A1 Sustained release drug delivery system containing codrugs
11/07/2002	WO2002087338A1 Liquid formulations for dermal application in treatment of parasitic insects in animals
11/07/2002	WO2002072635A3 Specific binding members
11/07/2002	WO2002020565A3 Collections of repeat proteins comprising repeat modules
11/07/2002	WO2001058480A9 Tubulin based vaccine against trypanosomiasis
11/07/2002	US20020165375 Parasitic helminth cuticlin proteins and uses thereof
11/07/2002	US20020165373 Contacting the sample with an isolated recombinant immunodominant Neospora antigen, forming an antigen/antibody complex, and detecting the presence or absence of the complex
11/07/2002	US20020165275 Trisubstituted carbocyclic cyclophilin binding compounds and their use
11/07/2002	US20020164381 Mixture containing sulfur and sulfur compound
11/07/2002	US20020164331 Compositions and methods of monoclonal and polyclonal antibodies specific for T cell subpopulations
11/07/2002	US20020164312 Therapeutic method and composition utilizing antigen-antibody complexation and presentation by dendritic cells
11/07/2002	CA2445338A1 G-protein coupled receptors
11/07/2002	CA2429001A1 Cysteine protease inhibitors
11/06/2002	EP1254270A1 Methods and materials relating to cub domain polypeptides and polynucleotides
11/06/2002	EP1254268A1 Methods and materials relating to leucine-rich repeat protein-like (lrr protein-like) polypeptides and polynucleotides
11/06/2002	EP1254224A2 Interferon-alpha induced genes
11/06/2002	EP1254212A2 Methods of preparing and using a viral vector library
11/06/2002	EP1254135A2 Aminoheterocyclylamides as pesticides and antiparasitic agents
11/06/2002	EP1254124A1 Dipeptide nitrile cathpsin k inhibitors
11/06/2002	EP1254123A1 2-benzothiazolyl urea derivatives and their use as protein kinase inhibitors
11/06/2002	EP1109818B1 Phosphoepoxides, method for making same and uses
11/06/2002	CN1378423A Active ingredient compositions having insecticidal and acaricidal properties
11/06/2002	CN1377968A Malignant malarial parasite new antigen candidate gene pfMAg
11/06/2002	CN1377967A Malignant malarial parasite dynein gene
11/05/2002	US6476026 Compounds and compositions as protease inhibitors
11/05/2002	US6476018 Fused imidazole derivatives as multidrug resistance modulators
10/2002
10/31/2002	WO2002086078A2 Synthesis and evaluation of novel phthalimide mimics as anti-angiogenic agents
10/31/2002	WO2002086069A2 Secreted proteins
10/31/2002	WO2002085888A1 Tetrahydropyridyl-alkyl-heterocycles, method for preparing same and pharmaceutical compositions containing same
10/31/2002	WO2002085870A1 Novel azoles having an insecticidal action
10/31/2002	WO2002085863A1 Novel compounds of the family of 3-alkyl-(4,5 diphenyl-imidazol-1-yl) and their use as soothing agents
10/31/2002	WO2002085859A1 HETEROARYL UREAS CONTAINING NITROGEN HETERO-ATOMS AS p38 KINASE INHIBITORS
10/31/2002	WO2002085303A2 Substituted tetracycline compounds for the treatment of malaria
10/31/2002	WO2002085093A2 Replikin peptides and uses thereof
10/31/2002	WO2001091535B1 A combination kit used in the treatment of malaria containing chloroquine and 3-(1-(((4-((6-methoxy-8-quinolinyl)amino)pentyl)amino)-ethylidene)-dihydro-2(3h)furanone enthält
10/31/2002	US20020161024 Administering 2-(piperidin-2,6-dion-3-yl),4-amino-isoindolin-1-one to treat an eye condition
10/31/2002	US20020160021 Carrier group coupled to an oligosaccharide obtained from a lipoglycan found on surface of an eukaryote, the composition being administered in an amount sufficient to elicit a protective immune response against the eukaryotic parasite
10/31/2002	US20020160000 PD-1, a receptor for B7-4, and uses therefor
10/31/2002	CA2444675A1 Secreted proteins
10/31/2002	CA2444592A1 Novel azoles having an insecticidal action
10/31/2002	CA2441540A1 Replikin peptides and uses thereof
10/30/2002	EP1252820A1 Pediculicidal and ovacidal treatment compositions and methods for killing head lice and their eggs
10/30/2002	EP1252141A1 Tosylproline analogs as thymidylate synthase inhibitors
10/30/2002	EP1251871A1 Pharmaceutical composition for immunomodulation and preparation of vaccines comprising an antigen and an immunogenic oligodeoxynucleotide and a polycationic polymer as adjuvants
10/30/2002	EP1251829A1 Electrospun pharmaceutical compositions
10/30/2002	CN1377364A Resticidal macrolides
10/30/2002	CN1377352A Selective antagonists of A28 adenosine receptors
10/30/2002	CN1377274A Treatment of chronic viral infections with i (M. Vannae)
10/30/2002	CN1376467A Veterinary medicine containing oxfendazole
10/30/2002	CN1376466A Solution-type oral liquid or injection containing triclabendazole
10/29/2002	US6472519 Plasmodium falciparum antigens inducing protective antibodies
10/29/2002	US6472371 Macrolides

1 ... 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 ... 218